In the United States<unk>  is indicated for the prevention of pregnancy in women with a BMI 2 for whom a transdermal delivery system is an appropriate method of contraception. In the European Union,<unk>  is indicated for use as female contraception.
Norelgestromin/ethinylestradiol
Ethinylestradiol/megestrol acetate
Ethinylestradiol/levonorgestrel
Segesterone acetate/ethinylestradiol
Nomegestrol acetate/estradiol
Ethinylestradiol/drospirenone
Ethinylestradiol/desogestrel
Ethinylestradiol/cyproterone acetate